A. Burchat

发表

Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection.

D. Borhani, R. Stachlewitz, D. J. Calderwood, 2006, Bioorganic & medicinal chemistry letters.

Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection.

D. Borhani, R. Stachlewitz, D. J. Calderwood, 2006, Bioorganic & medicinal chemistry letters.

Thienopyrrole acetic acids as antagonists of the CRTH2 receptor.

M. McPherson, Christopher M. Harris, Xiaoyun Wu, 2011, Bioorganic & medicinal chemistry letters.

Regioselectivity in electrophilic substitution of 5-aminoindoles and 5-aminoindolines: synthesis of pyrrolo[3,2-e]indoles and isomeric pyrrolo[2,3-f]indoles

G. Dmitrienko, Ian D. Watts, A. Burchat, 1991 .

Discovery of thienopyridines as Src-family selective Lck inhibitors.

D. J. Calderwood, Bryant H. Yang, G. Hirst, 2007, Bioorganic & medicinal chemistry letters.

Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck -- a selectivity insight.

D. J. Calderwood, K. Ritter, M. Friedman, 2002, Bioorganic & medicinal chemistry letters.

Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck II.

D. J. Calderwood, G. Tometzki, D. Johnston, 2000, Bioorganic & medicinal chemistry letters.

HTRF-Based Assay for Microsomal Prostaglandin E

Junjian Liu, E. Goedken, A. Burchat, 2013 .

HTRF-Based Assay for Microsomal Prostaglandin E2 Synthase-1 Activity

Junjian Liu, E. Goedken, M. Tomlinson, 2008, Journal of biomolecular screening.

Titration of alkyllithiums with a simple reagent to a blue endpoint

A. Burchat, J. Chong, N. Nielsen, 1997 .

2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimization.

Eric F. Johnson, R. Dixon, D. Borhani, 2010, Bioorganic & medicinal chemistry letters.

Observations on Sn-Li exchange in α-aminoorganostannanes and the configurational stability of non-stabilized α-aminoorganolithiums

Sheldon B. Park, A. Burchat, J. Chong, 1993 .

Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor

R. Dixon, D. Borhani, R. Talanian, 2012, BMC Structural Biology.

ChemInform Abstract: Pyrazolo[3,4-d]pyrimidines Containing an Extended 3-Substituent as Potent Inhibitors of Lck - A Selectivity Insight.

D. J. Calderwood, K. Ritter, M. Friedman, 2002 .